Skip to main content
. 2021 Jan 7;16(1):e0244853. doi: 10.1371/journal.pone.0244853

Fig 3. Survival comparison in severe and critical COVID-19 between TPE and non-TPE cohorts.

Fig 3

(a) For severe COVID-19 patients, OS of 100% and 90% (p = 0.08) in TPE and non- TPE patients respectively (b) for critical COVID-19 patients, OS of 81.8% and 40.9% (p = 0.007) in TPE and non TPE patients respectively. COVID-19, Coronavirus disease 2019, TPE, Therapeutic Plasma exchange, OS, overall survival.